Fig. 5From: An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastomaA nomogram incorporating risk score based on expression levels of eight mRNAs, age and pharmaceutical therapy for predicting survival of GBM patients. a, the sum of points for each variable value is located on Total Point axis, and used to determine likelihood of 1-year and 3-year overall survival of each individual patient. b, calibration plots of nomogram for predicting 1-year and 3-year overall survivalBack to article page